These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938 [Abstract] [Full Text] [Related]
3. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol; 2007 Oct 01; 79(10):1464-71. PubMed ID: 17705185 [Abstract] [Full Text] [Related]
6. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. J Med Virol; 2009 Mar 01; 81(3):441-5. PubMed ID: 19152397 [Abstract] [Full Text] [Related]
9. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Scand J Gastroenterol; 2008 Mar 01; 43(7):849-56. PubMed ID: 18584524 [Abstract] [Full Text] [Related]
10. High prevalence of occult hepatitis B in Baltimore injection drug users. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Hepatology; 2004 Jan 01; 39(1):51-7. PubMed ID: 14752822 [Abstract] [Full Text] [Related]
11. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients. Silva Cd, Gonçales NS, Pereira JS, Escanhoela CA, Pavan MH, Gonçales FL. Braz J Infect Dis; 2004 Dec 01; 8(6):431-9. PubMed ID: 15880234 [Abstract] [Full Text] [Related]
13. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A, HepaICONA and the ICONA Study Groups. Infection; 2009 Oct 01; 37(5):445-9. PubMed ID: 19669092 [Abstract] [Full Text] [Related]
15. Impact of occult HBV infection in HIV/HCV co-infected patients: HBV-DNA detection in liver specimens and in serum samples. Fabris P, Biasin MR, Giordani MT, Berardo L, Menini V, Carlotto A, Miotti MG, Manfrin V, Baldo V, Nebbia G, Infantolino D. Curr HIV Res; 2008 Mar 01; 6(2):173-9. PubMed ID: 18336266 [Abstract] [Full Text] [Related]
16. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Shetty K, Hussain M, Nei L, Reddy KR, Lok AS. Liver Transpl; 2008 Apr 01; 14(4):534-40. PubMed ID: 18324677 [Abstract] [Full Text] [Related]
17. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. Maida I, Ríos MJ, Pérez-Saleme L, Ramos B, Soriano V, Pegram PS, Mura MS, Sánchez-Margalet V, Saldívar-Cornejo I, Wilkin A, Babudieri S, Núñez M. AIDS Res Hum Retroviruses; 2008 May 01; 24(5):679-83. PubMed ID: 18462085 [Abstract] [Full Text] [Related]
18. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G. J Clin Virol; 2004 Mar 01; 29(3):160-6. PubMed ID: 14962784 [Abstract] [Full Text] [Related]